Complement Therapeutics GmbH (CTx), a clinical-stage biotechnology company developing next-generation therapeutics for complement-mediated diseases, today announced that the U.S. Food and Drug ...
The U.S. Food and Drug Administration (FDA) on Wednesday approved Omeros Corporation (NASDAQ: OMER) Yartemlea (narsoplimab-wuug) for hematopoietic stem cell transplant- associated thrombotic ...
Many novel treatment approaches are being investigated to halt progression of geographic atrophy (GA) or, potentially, even reverse the retinal damage. The major categories include novel complement ...
Novo Nordisk A/S has acquired Zaltenibart, a Phase 2 MASP-3 inhibitor, for up to $2.1 billion, signaling strong conviction in its long-term potential. NVO shares have declined ~20% since October, now ...
LONE TREE, Colo. — As fewer people go to school to be teachers and many leave the profession altogether, school districts are turning to alternative pathways to bring new teachers into classrooms. "I ...
Hosted on MSN
Alternative pathways helping Douglas County Schools fill jobs as Colorado seeks to curb teacher shortage
As fewer people go to school to be teachers and many leave the profession altogether, districts are turning to new options to bring new teachers into classrooms. Questions swirl around Donald Trump, ...
Texas will become the 13th state to offer an alternative licensure pathway for experienced international physicians this September, The Dallas Morning News reported Aug. 13. House Bill 2038 — called ...
I’M DISAPPOINTED. YOU KNOW, I DON’T THINK THIS IS HOW WE SHOULD TREAT OUR PARTNERS THAT ARE TRYING TO INVEST IN OUR CITY. BUT IN THE END, I THINK WHAT WE’LL SEE HERE IS JUST A HICCUP, A SETBACK THAT ...
In the retina, age-related macular degeneration (AMD) affects the complex of photoreceptors, retinal pigment epithelium (RPE), Bruch’s membrane (BM) and the choriocapillaris, the innermost layer of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback